Investor Watch


Monoclonal Antibody Produced by Indian & Cuban Partnership Enters U.S. Clinical Trials Targeting COVID-19 ARDS via San Diego Biotech

A U.S. biotech company called Equillium, Inc. recently received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to commence a Phase 3 clinical trial, referred to as EQUINOX. The company will now investigate itolizumab, a monoclonal antibody...

Columbia University-led Study Identifies Powerful Nasal Spray to Combat COVID-19 as Prophylaxis

With funding from both Columbia University Medical Center, New York, NY, and the National Institutes of Health (NIH), a multicenter, preclinical animal study, led by Columbia University Medical Center, and supported by researchers from Netherlands-based Erasmus...

Pin It on Pinterest